Synergistic Hypoxia and Apoptosis Conditioning Unleashes Superior Mesenchymal Stem Cells Efficacy in Acute Graft-versus-Host-Disease

Mohini Mendiratta,Meenakshi Mendiratta,Shuvadeep Ganguly,Sandeep Rai,Ritu Gupta,Lalit Kumar,Sameer Bakhshi,Vatsla Dadhwal,Deepam Pushpam,Prabhat Singh Malik,Raja Pramanik,Mukul Aggarwal,Aditya Kumar Gupta,Rishi Dhawan,Tulika Seth,Manoranjan Mahapatra,Baibaswata Nayak,Thoudam Debraj Singh,Sachin Kumar Singla,Mayank Singh,Chandra Prakash Prasad,Hridayesh Prakash,Sujata Mohanty,Ranjit Kumar Sahoo
DOI: https://doi.org/10.1101/2024.04.11.588248
2024-04-15
Abstract:Mesenchymal stem cells (MSCs) have emerged as promising candidates for immune modulation in various diseases that are associated with dysregulated immune responses like Graft-versus-Host-Disease (GVHD). MSCs are pleiotropic and the fate of MSCs following administration is a major determinant of their therapeutic efficacy. In this context, we here demonstrate that hypoxia preconditioned apoptotic MSCs [bone marrow (BM), Wharton’s Jelly (WJ)] bear more immune programming ability in a cellular model of acute Graft-versus-Host-Disease (aGVHD). To this purpose, we programmed MSCs by exposing them to hypoxia and inducing apoptosis both sequentially as well as simultaneously. Our findings demonstrated that WJ MSCs that were conditioned with indicated approaches simultaneously induced the differentiation of CD4 T-cell towards Tregs, enhanced Th2 effector, and concomitantly mitigated Th1 and Th17, with polarization of M1 effector macrophages towards their M2 phenotype, and more interestingly enhanced efferocytosis by macrophages indicated Th2 programming ability of MSCs programmed by conjunctional approaches Overall, our study highlights the potential of WJ-MSCs conditioned with hypoxia and apoptosis concurrently, as a promising therapeutic strategy for aGVHD and underscores the importance of considering MSC apoptosis in optimizing MSCs-based cellular therapy protocols for enhanced therapeutic efficacy in aGvHD.
Immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to improve the therapeutic effect of mesenchymal stem cells (MSCs) in acute graft - versus - host disease (aGVHD). Specifically, the researchers explored enhancing the immunomodulatory capacity of bone marrow (BM) - derived and Wharton’s Jelly (WJ) - derived MSCs through hypoxia preconditioning and apoptosis induction. ### Research Background - **The Role of MSCs**: MSCs show therapeutic potential in a variety of diseases related to immune response dysregulation due to their immunomodulatory properties, especially in aGVHD. - **The Fate of MSCs**: The fate of MSCs in vivo is crucial to their therapeutic effect. Studies have shown that MSCs after transplantation have a limited survival time in the host, will undergo apoptosis, and be phagocytosed by macrophages, and this process can further regulate the immune response. - **Hypoxic Environment**: MSCs usually exist in a hypoxic environment, which can promote their apoptosis and thus play a therapeutic role in vivo. ### Research Objectives - **Enhancing Immunomodulatory Capacity**: Treat MSCs simultaneously or sequentially through hypoxia preconditioning and apoptosis induction to enhance their immunomodulatory capacity. - **Optimizing Treatment Strategies**: Explore the effects of hypoxia preconditioning and apoptosis induction on the immunomodulatory capacity of MSCs to provide new strategies for the treatment of aGVHD. ### Main Findings - **Better Effect of WJ - MSCs**: The study found that WJ - MSCs with simultaneous hypoxia preconditioning and apoptosis induction can inhibit T - cell proliferation, promote Treg differentiation, reduce Th1 and Th17 cells, and increase the proportion of Th2 cells at the same time. - **Polarization of Macrophages**: These treated MSCs can also promote the transformation of M1 - type macrophages to M2 - type macrophages, further enhancing their immunomodulatory capacity. - **The Efficiency of Efferocytosis**: MSCs with simultaneous hypoxia preconditioning and apoptosis induction are more easily phagocytosed by macrophages, thus releasing more immunomodulatory molecules. ### Conclusion This study emphasizes the significant enhancement of the immunomodulatory capacity of WJ - MSCs by hypoxia preconditioning and apoptosis induction, providing new ideas and methods for the treatment of aGVHD. This not only helps to improve the therapeutic effect of MSCs but also provides a reference for the treatment of other immune - related diseases.